Showing posts with label Smoker. Show all posts
Showing posts with label Smoker. Show all posts

Tuesday, June 8, 2010

US cigarette brands expose smokers to higher levels of cancer-causing agents.

Moral of the story: Not only is smoking bad for, in fact will kill you, but smoking in the US is especially bad for you.  The real question is why on earth are US cigarettes so bad for you?  Are the companies aware of this?  Is the newly empowered FDA going to address this issue?

Source: AMA Morning Rounds 6/2/2010

US cigarette brands expose smokers to higher levels of cancer-causing agents.


CBS News (6/1) reported on its website that "'cigarettes from around the world vary in their ingredients and the way they are produced,' Dr. Jim Pirkle, deputy director for science at the CDC's National Center for Environmental Health, Division of Laboratory Sciences, said in a statement." But a newly-published paper appearing in Cancer Epidemiology Biomarkers and Prevention shows, "for the first time, the major carcinogens and cancer-causing agents in tobacco products, which researchers call tobacco-specific nitrosamines [TSNAs], were found in higher levels in US cigarettes than in cigarettes from" three other countries.
        Before reaching that conclusion, the "CDC team enlisted 126 regular smokers in Australia, Canada, Britain and, in the US, in New York and Minnesota," the Los Angeles Times (6/1, Maugh) "Booster Shots" blog reported. "All smoked one brand routinely, typically the most popular brands in their country." Minnesotans "smoked Marlboro, Newport, Marlboro Light and Camel Light, while those in New York smoked Marlboro, Newport, Newport Light, Camel Light and Marlboro Menthol." The researchers "focused on the most lethal carcinogen in the tobacco smoke, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), and its primary metabolite in urine, known informally as NNAL."

Wednesday, May 19, 2010

Hookahs not safer than cigarettes

Moral of the story: Hookahs may actually be worse than cigarettes in exposing people to more heavy metals and nicotine.  Stay away from both, they are bad.

Source: AMA Morning Rounds 5/18/2010

Hookahs, other water pipes mistakenly believed by many to be safer than cigarettes.


The New York Times (5/18, D6, Rabin) reports that after mailing "questionnaires in 2007 and 2008 to 1,208 people ages 18 to 24," researchers in Canada found that "many young people seem to believe that hookahs and other water pipes are safer than cigarettes." According to the authors of the Pediatrics paper, one myth involved young adults thinking that "because the texture is smoother, it is less toxic" and believing that "the water filters out the toxins." But, "that is not at all true," investigator Jennifer O'Loughlin asserted. "In fact, she said, the pipes may expose smokers to higher amounts of nicotine and heavy metals than cigarettes."

Sunday, March 21, 2010

Smokers who quit may experience improved arterial health within one year.

Moral of the story: 1 YEAR! that is amazing. quit smoking and you will see benefits almost immediately

Source: AMA Morning Rounds 3/16/2010

Smokers who quit may experience improved arterial health within one year.


NBC Nightly News (3/15, story 8, 0:20, Williams) reported that there is a "new incentive for smokers to quit" considering a "big new study...says quitting can improve artery function" and "actually make blood vessels healthier."
        Indeed, the work coming out of the University of Wisconsin-Madison indicates that people tend to "pick up pounds" when they quit smoking, the AP (3/16, Marchione) reports. But "a year after kicking the habit, smokers' arteries showed signs of reversing a problem that can set the stage for heart disease," according to the paper in the Journal of the American College of Cardiology.
        In fact, the "benefit was the equivalent of a 14% reduction in the risk of cardiovascular disease," the Milwaukee Journal Sentinel (3/15, Fauber) noted. Investigators reached that conclusion by using "a test known as flow-mediated dilation, which uses ultrasound to look at the ability of the brachial artery to relax." Participants who "who quit smoking had an improvement in flow-mediated dilation from 6.2% to 7.2%."

Survey finds many Americans drink, smoke, and don't exercise.

Moral of the story: Stop smoking, stop drinking, EXERCISE! Encourage others to do the same.

Source: AMA Morning Rounds 3/17/2010

Survey finds many Americans drink, smoke, and don't exercise.


USA Today (3/17, Hellmich) reports that, according to data from "the National Health Interview Survey, based on telephone interviews with 79,000 adults over three years," the US "is not a nation of teetotalers or regular exercisers." In fact, "61% of people in the USA drink alcohol," while "31% of people do enough regular leisure-time physical activity to get health benefits -- that is, moderate exercise for 30 minutes five times a week or vigorous activity for 20 minutes three times a week." Health statistician Charlotte Schoenborn, of the National Center for Health Statistics, said, "There has been no progress at all in increasing physical activity since we started doing this report in 1997."
        "Overall, researchers say that since 1997, rates of cigarette smoking have declined by several percentage points, rates of obesity have climbed, and rates of alcohol use, exercise, and sleep have remained relatively unchanged," WebMD (3/16, Warner) reported. The survey also found that "one in five adults were smokers," while "six in 10 adults were obese or overweight," and "three in 10 adults averaged six hours of sleep or fewer per night."

Sunday, November 29, 2009

Vaccines against cocaine, nicotine addiction modeled after infectious diseases research.

Moral of the story: A really cool idea that may just help people quit smoking, completely.

Source: AMA Morning Rounds 11/16/09

Vaccines against cocaine, nicotine addiction modeled after infectious diseases research.

USA Today (11/16, Rubin) reported, "Researchers are investigating whether the same approach used to prevent infectious diseases could treat addictions." Nicotine and cocaine molecules "are so tiny that they easily pass from the bloodstream into the brain." A vaccine, however, can stimulate the production of antibodies that "bind with the molecules," making the combo "far too large." No such vaccines are "on the market, but in late September, NIDA released a $10 million stimulus grant to Nabi Pharmaceuticals to help pay for the first Phase III trial...of a smoking-cessation vaccine." And, a paper published in the Archives of General Psychiatry carried successful "results of a cocaine vaccine study." The study's lead author, however, pointed out that "no company is interested in developing a cocaine vaccine because of liability concerns and the assumption it wouldn't be nearly as profitable as a nicotine vaccine."

Friday, June 26, 2009

Tobacco, Public Health, and the FDA

Moral of the story: The FDA and local governments can now finally treat tobacco as the addictive substance that it is, protecting the health of Americans and decreasing costs ($96B).

Tobacco, Public Health, and the FDA
Gregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D.
Published at www.nejm.org June 22, 2009 (10.1056/NEJMe0905622)

More than a decade ago, David Kessler, then Commissioner of the Food and Drug Administration (FDA), launched a bold initiative to regulate tobacco. He believed that since nicotine is an addictive substance, it fell under the statutory authority of the FDA to regulate it as a drug and cigarettes as the delivery vehicle.
His effort failed, however, when the U.S. Supreme Court decided in a 5-to-4 ruling (FDA v. Brown & Williamson Tobacco Corp.) that the Food, Drug, and Cosmetic Act of 1938, which defined the FDA's authority, did not grant the agency jurisdiction to regulate tobacco. Writing for the Court, Justice Sandra Day O'Connor concluded that "it is plain that Congress has not given the FDA the authority to regulate tobacco products."1 The Court's decision was based on its reading of the statutory language in the act, not on what was best for the health of the public.
Today, President Barack Obama changed all that. With the signing of the Family Smoking Prevention and Tobacco Control Act of 2009, which was passed by sizable majorities in both the House and the Senate (and which we endorsed), the FDA has been given broad authority to regulate tobacco products. We believe that this historic legislation can have an unparalleled positive impact on the health of the American public.
The act establishes the Center for Tobacco Products, a unit within the FDA that will be funded by user fees from tobacco manufacturers and importers — $235 million in fiscal year 2010, rising to $712 million over the next 10 years. The center is charged with regulating tobacco products for the explicit purpose of protecting the health of the public. The FDA will now have the authority to require that all ingredients, compounds, and additives in tobacco products be reported to the agency, and those found to have harmful health effects may be banned. Nicotine levels in cigarettes may be regulated, but neither nicotine nor cigarettes may be banned outright. In keeping with the act's focus on protecting those under 18 years of age, flavorings in cigarettes, which are meant to appeal to young smokers, are banned, with the exception of menthol, which could be banned later if found to be a health hazard. No new tobacco product can be marketed unless first approved by the FDA.
Importantly, the act will also allow regulation of so-called modified risk tobacco products, which are typically identified by terms on the package such as "light," "low," or "mild." The use of such terms will no longer be permitted unless the product has been shown to significantly reduce harm. Warning labels on cigarette packages will be made more graphic and will require the use of color. Tobacco companies may no longer sponsor sporting events.
For the first time in almost 40 years, state and local governments will be allowed to regulate the marketing of tobacco, establishing restrictions that may be more rigorous than those of the FDA. In addition, the act requires that the 1996 Tobacco Rule, which was put in place by Commissioner Kessler and deemed unconstitutional by the Supreme Court, must be reinstated. This rule places restrictions on tobacco advertising, including a ban on outdoor advertising within 1000 ft of a school. It is anticipated that this regulation may be the focus of a constitutional challenge on the basis that such advertising represents commercial speech subject to First Amendment protection. Still, there is good reason to believe that this carefully crafted provision, which is narrowly tailored to focus on smoking prevention in the nation's young, will survive any such legal challenge.
The long-term impact of the Family Smoking Prevention and Tobacco Control Act on the health of the public will depend critically on its implementation through strict regulations, rigorously enforced. FDA Commissioner Margaret Hamburg and Principal Deputy Commissioner Joshua Sharfstein promise to be strong advocates for rigorous enforcement.
In a recent article in the Journal, Hamburg and Sharfstein laid out their new mission.2 They regard the FDA as a public health agency whose purpose is not just to regulate the nation's food and drug supplies, but to protect the health of American citizens. Hamburg has also indicated that she is eager to undertake the regulation of tobacco and said in an interview, "We now have an opportunity to really make a difference with what is probably the No. 1 public health concern in the nation and the world."3
Few threats to the health of the public are as onerous as tobacco. Each year more than 435,000 Americans die of tobacco-related illnesses, principally heart, vascular, and lung diseases. Tobacco use is also associated with substantial morbidity and diminished quality of life. More than one in five Americans still smoke, an astonishing figure given the overwhelming evidence of harm. In addition to excess morbidity and mortality, tobacco adds considerably to health care costs at a time when reducing costs is a national priority. The total annual health care expenditures caused by smoking run to $96 billion.4 Along with other critical prevention goals, such as controlling obesity and increasing levels of physical activity, the elimination of cigarette smoking is central to improving the health of our citizens and mitigating the growth of health care costs.
The Family Smoking Prevention and Tobacco Control Act of 2009 comes at a propitious moment in U.S. history. We strongly support the FDA's new leaders and urge them to implement the act aggressively. As a medical journal, we are committed to eliminating the public health threat tobacco represents to American society and the world.
Source Information
This article (10.1056/NEJMe0905622) was published on June 22, 2009, at NEJM.org.
References

FDA v. Brown & Williamson Tobacco Corp. 529 U.S. 120 (2000).
Hamburg MA, Sharfstein JM. The FDA as a public health agency. N Engl J Med 2009;360:2493-2495. [Free Full Text]
Harris G. New F.D.A. chief says she'll toughen enforcement efforts. New York Times. June 17, 2009:A19.
Campaign for Tobacco-free Kids. Toll of tobacco in the United States of America. April 2009. (Accessed June 22, 2009, at http://www.tobaccofreekids.org/research/factsheets/pdf/0072.pdf.)

Sunday, December 21, 2008

ACIP Provisional Recommendations for Use of Pneumococcal Vaccines

Moral of the story: Do you smoke? Are you asthmatic? Then get this vaccine! Smokers have been added to those who the CDC will recommend receive the vaccine to guard against a certain type of pneumonia.
  • smokers (19 and older)
  • asthmatics (19 and older)
  • People without a functioning spleen
  • Adults 65 and older
  • Anyone 2 and older with a weakened immune system (HIV, cancer
  • Anyone 2 and older with a chronic disease (diabetes, COPD, emphysema, sickle cell anemia, or any other heart, lung, kidney, or liver disease including alcoholics)
The vaccine is 23-valent pneumococcal polysaccharide vacine (PPSV23). It protects against 23 types of Streptococcus pneumoniae that cause a sever type of pneumonia that has a mortality rate near 20%. ACIP is the CDC's Advisory Committee on Immunization Practices - the CDC usually adopts their recommendations.

Provisional Recommendations for Use of Pneumococcal Vaccines

http://www.cdc.gov/vaccines/recs/provisional/downloads/pneumo-oct-2008-508.pdf

Date of ACIP vote: October 22, 2008
Date of posting of provisional recommendations: December 8, 2008
On October 22, 2008, the ACIP voted on new and revised recommendations for the use of 23-valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of invasive pneumococcal disease. The new provisional recommendations are as follows:

1. Recommendation for use of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) among adult cigarette smokers:
Adults who smoke cigarettes are at substantially increased risk for invasive pneumococcal disease. The ACIP recommends that cigarette smoking should be added to the list of indications for PPSV23 in adults aged 19 through 64 years. Proposed wording of the revised recommendation: Persons aged 19 through 64 years who smoke cigarettes should receive a single dose of PPSV23 and smoking cessation counseling.

2. Recommendation for use of PPSV23 among adults who have asthma:
Asthma is an independent risk factor for invasive pneumococcal disease. The ACIP recommends that asthma should be included among the chronic pulmonary diseases (such as COPD and emphysema) that are indications for PPSV23 in adults aged 19 through 64 years. Proposed wording of the revised recommendation: “Persons aged 19 through 64 years who have asthma should receive a single dose of PPSV23.”